Redeye: Enea - Past its nadir and building momentum
Enea’s report aligned with Redeye’s estimates (RRe) on a constant currency basis. Post-quarter end, Enea announced a large extension on the Stratum product with an incremental value of USD5m-9m. Enea is valued at an EV/S 2025e of 2.2x and an EV/EBITDAC on 2025e of 9.4x, with good margins and mid-single-digit-to-low double-digit growth. Redeye raised its estimate and fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/